Post marketing surveillance on safety and efficacy of IMOD in Iranian patients with HIV/AIDS.
Mohraz M, Sedaghat A, SeyedAlinaghi S, Asheri H, Mohammaddoust S, Gharibdoost F, Khorshid HR, Farhadi M, Madani SH, Kamali K.
Mohraz M, et al. Among authors: khorshid hr.
Infect Disord Drug Targets. 2013 Feb;13(1):71-4. doi: 10.2174/18715265112129990031.
Infect Disord Drug Targets. 2013.
PMID: 23713668
Clinical Trial.